Nicolas Hubacz: Immune Cells in the Embryo
Nicolas Hubacz, Advisory Board Member at Drug Target Review, Founder of NH Sponsorships, Biotech Club Mentor at UT Southwestern Medical Center, Clinical Products US West Business Development Manager at Magstim, shared a post on LinkedIn about a recent article by Hoang Anh Le et al. published in Nature Cell Biology, adding:
“Immune Cells in the Embryo
In this video, you’re seeing embryonic myeloid cells (red), among the earliest immune cells to emerge during development, spreading across developing frog tissue (blue).
New research shows that these cells aren’t navigating alone. The physical movement of surrounding tissue helps guide their migration.
As embryonic tissue spreads outward, early immune cells move along with it.
But they aren’t simply being carried by the flow. The cells reorganize their internal cytoskeleton and extend protrusions in the direction of tissue movement, allowing them to actively migrate with it.
This suggests that mechanical forces generated during development can provide directional cues to immune cells, helping them disperse throughout the embryo and establish an early line of defense.
Understanding how tissue movement guides immune cells could also reveal mechanisms involved in wound healing, inflammation, and cancer.
Video from work by Hoang Anh Le and colleagues, Department of Cell and Developmental Biology, University College London.
Research published in Nature Cell Biology, September 2026.”
Title: Tissue flow acts as a guidance cue for immune cell polarization and directional migration
Authors: Hoang Anh Le, Jonas Hartmann, Ricard Alert, Roberto Mayor
Other posts featuring Nicolas Hubacz on Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC